SC
MRNA icon

SouthState Corp’s Moderna MRNA Stock Holding History

SouthState Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75K Hold
39
– – ﹤0.01% 891
2026
Q1 		$1.99K Buy
39
+15
+63% +$700 ﹤0.01% 902
2025
Q4 		$714 Sell
24
-59
-71% -$1.6K ﹤0.01% 1173
2025
Q3 		$2.15K Sell
83
-244
-75% -$6.81K ﹤0.01% 922
2025
Q2 		$9.03K Buy
327
+143
+78% +$3.77K ﹤0.01% 804
2025
Q1 		$5.22K Buy
+184
New +$6.53K ﹤0.01% 977
2024
Q4 		– Hold
0
– – – 672
2024
Q3 		– Sell
-22
Closed -$2.02K – 607
2024
Q2 		$2.64K Buy
+22
New +$2.78K ﹤0.01% 581
2023
Q4 		– Sell
-220
Closed -$22.7K – 653
2023
Q3 		$22.7K Buy
220
+70
+47% +$7.81K ﹤0.01% 396
2023
Q2 		$18.2K Hold
150
– – ﹤0.01% 425
2023
Q1 		$23K Hold
150
– – ﹤0.01% 430
2022
Q4 		$26.9K Hold
150
– – ﹤0.01% 435
2022
Q3 		$18K Hold
150
– – ﹤0.01% 473
2022
Q2 		$21K Hold
150
– – ﹤0.01% 489
2022
Q1 		$26K Hold
150
– – ﹤0.01% 508
2021
Q4 		$38K Hold
150
– – ﹤0.01% 430
2021
Q3 		$58K Buy
+150
New +$55.3K ﹤0.01% 340

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

SouthState Corp's MRNA Position: Q2 2026 in Review

SouthState Corp held its Moderna (MRNA) position steady in Q2 2026 at 39 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

SouthState Corp first reported a position in MRNA in Q3 2021 and has held it in 16 quarters since. The position peaked at $58K in Q3 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SouthState Corp held 39 shares of Moderna worth $2.75K as of Q2 2026.
  • SouthState Corp left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #891 holding.
  • SouthState Corp first reported a position in Moderna in Q3 2021 and has held it in 16 quarters since.
  • SouthState Corp's Moderna position peaked at $58K in Q3 2021.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.